Showing 281-290 of 767 results for "".
New Products
https://practicaldermatology.com/columns/new-products/new-products/20668/Digital Photomapping (DPM) in Mohs
https://practicaldermatology.com/topics/general-topics/digital-photomapping-dpm-in-mohs/20682/Systemic Effects of UV Radiation: The Case for Apoptosis of Peripheral Blood Mononuclear Cells
https://practicaldermatology.com/topics/general-topics/PD0709_11-php/22806/Mechanisms of UV-mediated tumorigenesis and development are not fully understood. Findings suggest apoptosis of peripheral blood mononuclear cells may play a role.High Risk SCC: What Factors Predict Recurrence and Metastasis?
https://practicaldermatology.com/topics/general-topics/PD1208_12-php/22609/Data shed light on risk factors associated with aggressive SCC, allowing dermatologists to identify and properly follow high-risk patients.Case Report: Minimal Incision Extraction for Large Lipomas
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-minimal-incision-extraction-for-large-lipomas/21189/On Dosage and Diet: Isotretinoin 101
https://practicaldermatology.com/topics/general-topics/on-dosage-and-diet-isotretinoin-101/21445/Isotretinoin is one of the most essential agents in the treatment of acne, but dietary and dosage considerations must be made to maximize efficacy. Author:Joshua Zeichner, MDThe Osteopathic Dermatologist: Dr. Peter Ilowite Shares His Craft
https://practicaldermatology.com/topics/practice-management/the-osteopathic-dermatologist-dr-peter-ilowite-shares-his-craft/21116/First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Management of Atopic Dermatitis During the COVID-19 Pandemic
https://practicaldermatology.com/topics/atopic-dermatitis/management-of-atopic-dermatitis-during-the-covid-19-pandemic/23322/There is concern about the immunosuppressive or immunomodulatory effects of oral and biologic medications in patients with skin disease.New Products and Pharmacological Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacological-developments/20345/